Home >> News >> Business >> Global Insomnia Treatment Drugs market report just published by Credence Research Inc.

Global Insomnia Treatment Drugs market report just published by Credence Research Inc.

The purpose of the report is to illustrate the state of the market of Blood Processing Devices and Consumables, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026. [Continue Reading]

Market Insights:

As per the scientific evidences reported by American Psychiatric Association (APA) approximately one third of the adults suffer with insomnia during their lifetime. It is manifested by incessant problems in falling and staying asleep. Patients suffering with insomnia experience symptoms such as fatigue, mood disturbances, lack of concentration, low productivity, loss of appetite etc. Pharmaceutical companies are relentlessly working to provide effective medication with least side effects. Orexin antagonist (Belsomra) are being prescribed by physicians throughout the globe owing to its ability to improve sleep with high degree of tolerability and limited adverse effects profile. The insomnia treatment drugs market pose severe threat from alternative treatment such as cognitive behavioral therapy for insomnia (CBTI) and recent FDA approval of devices such as Fisher Wallace Stimulator and EBB Insomnia Therapy.

Prescription sleep aids dominate the treatment type segment on account of key factors such as rising prevalence of insomnia, increasing stress, addiction etc., which if untreated will eventually result in chronic illness. Demanding lifestyle and poor sleeping habits result in secondary insomnia which requires benzodiazepines in combination with zolpidem for its treatment. Antidepressants are prescribed for patients suffering with neuropsychiatric ailment. Over the counter sleep aids comprises of antihistamines, melatonin and dietary supplement. Antihistamine and melatonin are utilized to produce sedative effect in patients suffering with altered circadian rhythm and jet lag. Dietary supplements are usually taken by patients to stimulate the production of melatonin by pineal gland. [Continue Reading]

Leading Players:

Merck & Co. Inc., F.Hoffman La-Roche AG, Mylan N.V., Pernix Therapeutics, Pfizer, Inc., Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co. Ltd., Teva Phamaceutical Industries Ltd,  and Vanda Pharmaceuticals, Inc….

Browse here for full report with Toc: https://www.credenceresearch.com/report/insomnia-treatment-drugs-market

Why was the report written?

This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Insomnia Treatment Drugs buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.

What is the current market landscape and what is changing?

Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.

The report on the market of Insomnia Treatment Drugs contains:

Analysis and forecast of Insomnia Treatment Drugs market dynamics;

Analysis of domestic production, market shares of the main market players;

Analysis of exports and imports;

Analysis of factors, leading the development of the Insomnia Treatment Drugs market;

Assessment and forecast of Insomnia Treatment Drugs market development;

Financial and business profiles of the leading companies in theInsomnia Treatment Drugs industry.

Scope                                                                                

– Up to date working Insomnia Treatment Drugs data by major regions in the world, the forecast of planned capacity additions by 2026

– The annual breakdown of capital expenditure spending on proposed Insomnia Treatment Drugs for the period 2018 to 2026

– Planned Insomnia Treatment Drugs additions and capital expenditure spending by key countries and companies across the world

– Planned capital expenditure spending on new Insomnia Treatment Drugs projects by region, key countries, and companies

– Details of major planned Insomnia Treatment Drugs projects in the world up to 2026

Browse here for full report with Toc: https://www.credenceresearch.com/report/insomnia-treatment-drugs-market

Also you can request us for sample in pdf with more details and graph:https://www.credenceresearch.com/sample-request/59249

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:

Credence Research Inc.

105 N 1st ST #429

SAN JOSE

CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290

Web: https://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *